Prioritizing development of RP-A501 (Danon disease), RP-A601 (PKP2-ACM), and RP-A701 (BAG3-DCM) to advance AAV cardiovascular gene therapy platform for sustained value creation FDA RMAT designation ...
Hosted on MSN
Carspotting: “Moon Rocket” In Progress
A rare color photo of the future Moon Rocket illustrates the mild-custom treatment that earned Jerry Anolik’s 1955 Thunderbird surprise selection as People’s Choice of the entire 1957 Oakland Roadster ...
Relativity Space, the 3D-printed rocket company that managed one launch from Cape Canaveral in 2023, announced Monday it was changing CEOs during an update on its in-the-works replacement rocket.
Hosted on MSN
Why Rocket Lab Is Up Big Today
Rocket Lab USA (NASDAQ: RKLB) has been selected to bid for billions in future launches planned by the United States and United Kingdom. Investors are excited about the opportunities these selections ...
Leadership updates with the appointments of Dr. Syed Rizvi, Chief Medical Officer, Christopher Stevens, Chief Operating Officer, and Sarbani Chaudhuri, Chief Commercial & Medical Affairs Officer Cash, ...
Phase 2 pivotal study of RP-A501 for Danon disease is ongoing; Program update expected mid-year 2025 Initial data from the Phase 1 study of RP-A601 for PKP2-ACM anticipated May 2025 IND submission for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback